A New Entry In Evolution Controversy

The Blind Watchmaker. Richard Dawkins. W.W. Norton and Company, New York, 1986. 332 pp., illus. $18.95. Well-informed, imaginative and stylistically pleasing introductions to evolution and the theory of natural selection have hitherto been the special preserve of Stephen J. Gould. Hitherto—but not hereafter. Richard Dawkins' The Blind Watchmaker bids fair to become at least as influential a guide to controversies in evolutionary theory as the best of Gould's wonderful books. This is probab

Written byAlexander Rosenberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

But controverting the views of other evolutionary biologists is not Dawkins' aim at all. Instead, he wants to expound the theory of natural selection, and to show that it, and it alone, can explain the most puzzling facts about the incredibly sophisticated engineering feats that the organization of living things reveals. His aim is to show that only Darwinian theory can account for the very facts of optimum design and apparently intentional construction that have long provided the most satisfying argument for the existence of God. In this aim Dawkins has been entirely successful.

Dawkins begins by setting up the case for conscious design and an omnipotent designer through an example, detailing the magnificent system of echo-location employed by bats. It embodies a set of components that would do credit to the best contemporary defense technology: an unjammable pulsed Doppler send/receive frequency modulation device reflecting every nuance of the most ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies